Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (1)
Select solutions (2)
Active Filters (3)
Clear All
1 - 10 of 10 Results
Sort by:
Best Match
Whitepaper
The evolving landscape of quality by design in biologics manufacturing
Implement QbD principles to meet safety, efficacy, and consistency challenges in biologics manufacturing
Infographic
Addressing the challenges in modern biotherapeutic development
Explore next-generation approaches to enable the development and characterization of bispecific and multi-specific antibodies
Infographic
Safety rules with Revvity biotherapeutic workflows
Improve safety and efficacy of your GMP manufacturing workflows with this infographic exploring Revvity instruments, reagents and assays.
Whitepaper
Learning from our ancestors: can we be better prepared for the next pandemic?
Researchers have found evidence of an ancient viral epidemic involving host coronavirus interacting genes in East Asia more than 20,000 years ago. These findings could help countries prepare for future pandemics.
Whitepaper
A brand-new modality on the horizon: how targeted protein degradation can address the unmet need in drug discovery and development
Discover the potential of Targeted Protein Degradation (TPD) as an emerging drug discovery modality. Explore how TPD enables the selective targeting and degradation of proteins, even those previously considered "undruggable."
Brochure
Comprehensive drug discovery workflows brochure
This brochure details our comprehensive drug discovery solutions. It covers every stage, from target selection to product development, helping to accelerate preclinical drug development with confidence.
Brochure
Biologics workflow solutions
Revvity can help you discover and develop high-quality biological drug products by streamlining the biologics workflow.
Literature - Publication Review
Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into one of three categories: Antivirals, antibodies, or protein-protein interaction inhibitors.
Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.
Brochure
Pooled functional genomic screening solutions and services
Functional genomic screening has the potential to reshape drug discovery, enhance our understanding of biological systems, and revolutionize personalized medicine.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.